QPI 3000R
Alternative Names: QPI-3000RLatest Information Update: 18 Feb 2021
At a glance
- Originator Quark Pharmaceuticals
- Class Small interfering RNA
- Mechanism of Action RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Hearing loss
Most Recent Events
- 04 Feb 2021 Early research in Hearing loss in USA (unspecified route) before February 2021 (Quark Pharmaceuticals pipeline, February 2021)